Wow. Authoritarian tyrants blocking bank accounts for protesting. Well, at least they're not blocking bank accounts for simply DONATING to protesters like the FUKCING TYRANT JUSTIN TRUDON'T.
Holy crap: VAxxed die at higher rates! Who knew? (We knew and we kept telling you NPC's). UK Health system data.
This nonsense from you about deaths in the U.K. has already been debunked in great detail many times. You need to keep in mind base rate fallacy and age distribution. Even the U.K. health authorities came out and directly debunked the nonsense you are attempted to push related to this chart.
Record approval for a Harmceutical product. https://igorchudov.substack.com/p/f..._id=89428031&isFreemail=true&utm_medium=email FDA Approves Bivalent Vaccine for Babies in TWO DAYS - NO TESTING. It's an IQ test: do you support this or say no to the murder of infants. If you're lib, we already know - you LOVE abortion, so you'll love murdering children this way, too.
Any vaccine that goes through a minor change in targeted formulation does not require full re-approval with Phase 3 trials, etc. anywhere on the face of the globe. For example, the flu vaccine is updated every year to change the targeted flu strains. Re-approval is not required for the updated flu vaccine. The same with many other vaccines which target new strains that have evolved. However all of this has been explained numerous times -- but the anti-vax misinformers will keep pushing their fabrications regarding it.
60 doctors (and 120 total medical professionals) sign a letter protesting the approval of the murder shot for 6 month + kids. Dame June Raine, CEO, Medicines and Healthcare products Regulatory Authority Cc: Professor Lim Wei Shen, Joint Committee on Vaccination and Immunisation; Professor Sir Munir Pirmohamed, Chair, Commission on Human Medicines; Rt Hon Stephen Barclay, Secretary of State, Department of Health and Social Care 4th December 2022 Dear Dame June, Re: Conditional Marketing Authorisation for Covid-19 vaccines for 6 months-5 years We understand that Moderna has applied for an extension of its CMA down to infancy, following agreement by the European Medicines Agency. We are writing to strongly recommend against such an action and also against the possibility of introducing Covid-19 vaccines into the routine children’s immunisation programme, for the following reasons, many of which have already been shared with the FDA: Firstly, as for other paediatric age-groups, the risks from SARS-CoV-2 infection is extremely low, with only 6 deaths in England in the 1-4s age group from Covid-19 in the whole of 2020 and 2021. Most infected toddlers remained asymptomatic or with trivial upper respiratory symptoms, even prior to the arrival of the much milder omicron variants. This alone makes it incomprehensible as to why any medical body would decide that a vaccine would be indicated. Secondly, it is clear that the currently available vaccines have a very poor efficacy over time. For adults, this lack of durable efficacy has resulted in the need to recommend ongoing boosters, given every few months, with efficacy apparently reducing further for each new variant. This was largely predictable, since these are not sterilising vaccines, and provide no upper airway immunity, necessary to provide effective immunity against respiratory viruses. Vaccine efficacy also wanes more quickly after the paediatric dose (which is lower than the adult dose), with negative efficacy in 5-11s within only 6 weeks of the second dose of Pfizer. This weakness and brevity of protection negates any notion that adults will be protected by the vaccination of children. Adults will be better protected if children have natural infection, thereby deriving longer-lasting and broader immunity. Thirdly, it is well established that young children have a much more effective innate immune system than adults and at this point the vast majority of under 5-year-olds have already been immunologically exposed to SARS-CoV-2 repeatedly, whether or not actively infected. Meeting these viruses early in life will allow protective immunity to develop for the decades ahead. A degree of immune imprinting has been recognised with the adult vaccines, rendering vaccine escape inevitable. Observed alterations in IgG responses with repeated doses have unknown implications for the developing immune system. Due to the lack of long-term data, concerns about antibody dependant enhancement (ADE) remain unanswered, making this an unacceptable future risk for children. Fourthly, the safety profile of the novel, gene-based mRNA vaccines is very far from perfect. The balance of benefit and risk, used to support the rollout of mRNA vaccines to the elderly and vulnerable in 2021, is inappropriate and inapplicable for healthy children in 2022, especially given the negligible hazard that the virus poses to them. In adults, adverse event reports in all official safety surveillance systems, eg VAERS, Yellow Card and EudraVigilance, have reached unprecedented levels, with the VAERS reporting systems showing reported fatalities after Covid-19 vaccines several-fold higher than any previous vaccine. Reports of myocarditis in adolescents have been shrugged off as ‘mild and settle quickly’, despite reports to the contrary. No evidence is available to support the confident assertion that the inevitable heart tissue scarring resulting from myocarditis will not lead to serious heart problems and dysfunction 5-10 years down the line. Indeed, Pfizer and Moderna are only now embarking on 5-year follow-up studies which should have been required from the outset. Adverse event reports in the US, where vaccination has already begun in the pre-school age-group, have tragically included 11 deaths in this cohort to date, likely to be an underestimate. There is evidence of a complex functional reprogramming of the innate immune response. Most concerning for a children’s vaccine is the total lack of any long-term safety data to rule out any unexpected negative impact on long-term health or fertility, which should make it unethical to even consider administration to healthy children. Fifthly, these novel-technology gene products were given an exemption from standard reproductive toxicity, genotoxicity and carcinogenicity animal studies before being rolled out to humans, and indeed have not even had published biodistribution and pharmacokinetic studies. The manufacturers have provided no data on how much spike protein is produced by different people and for how long – this is of great concern as the dose of and duration of exposure to the spike protein may differ by orders of magnitude between individuals, resulting in huge variance in individual susceptibility to adverse events and harm. The initial claim that the vaccine would remain at the injection site is also, clearly, totally without foundation, which raises the concern that the mRNA lipid nanoparticles or the subsequently produced spike protein may cross the blood-brain barrier or placenta, resulting in inflammation and cell destruction in the brain or fetus by the host immune system. Also of concern, published studies have clearly shown that these products negatively affect T-cell function, and hence the ability of the body to fight not only infections but also to clear cancerous cells. At this point, there is far too much evidence of harm to multiple systems and organs to ignore, and we have an ethical duty of care to protect our healthy children from iatrogenic harm. Finally, the research basis for the toddler vaccines was woefully inadequate. Follow-up was for a median of 70 days after the second dose; this is contrary to international guidelines which recommend at least one year follow-up. Efficacy was estimated at only 37% for 2-4-year-olds, bringing it far below what is usually considered an acceptable efficacy to justify use of a vaccine, and in the younger group prevention of asymptomatic infection at a mere 3.8% with confidence intervals from -111 to +53% should have made this vaccine a complete non-starter for this cohort. The use of ‘immuno-bridging’ (presence of an antibody response) was relied upon as a proxy for preventing symptomatic disease and gives no real-world data to ascertain true effectiveness. Local and systemic side effects were common, especially after the second dose, with post-vaccine fever more common in those with previous SARS-CoV-2 infection. Shockingly, several severe adverse events including a case of Type 1 diabetes, a lifelong, life-limiting disease, were hidden in the supplementary appendix, which brings into question the transparency of the data. There has been a stated concern from public health bodies about an increase in vaccine hesitancy. Rolling out a rushed pharmaceutical product with known short-term risks and unknown long-term risks to an age group that cannot benefit in any meaningful way can only fuel public doubt in the scientific rigour of the authorisation process. This could undermine the entire childhood immunisation programme and lead to further vaccine hesitancy. It can already be seen in the US that uptake for this young age is extremely low – parents are voting with their feet. Until all these short- and long-term safety concerns have been rigorously investigated and ruled out, and a significant need and benefit for the vaccine in this cohort has been demonstrated, the precautionary principle and fundamental ethical principles of science and medicine must preclude any further authorisations. Dr Rosamond Jones, MBBS, MD, FRCPCH, retired consultant paediatrician, on behalf of members of CCVAC (Children’s Covid Vaccines Advisory Council) and many others, including: Professor Anthony J Brookes, Professor of Genomics & Health Data Science, University of Leicester Professor Angus Dalgleish, MD, FRCP, FRACP, FRCPath, FMedSci, Professor of Oncology, St George’s Hospital, London Professor Richard Ennos, MA, PhD. Honorary Professorial Fellow, University of Edinburgh Professor John A Fairclough, BM BS, BMed Sci, FRCS, FFSEM(UK), Professor Emeritus, Honorary Consultant Orthopaedic Surgeon Professor Norman Fenton, CEng, CMath, PhD, FBCS, MIET, Professor of Risk Information Management, Queen Mary University of London Professor David Livermore, BSc, PhD, retired Professor of Medical Microbiology Professor Dennis McGonagle, PhD, FRCPI, Consultant Rheumatologist, University of Leeds Professor Roger Watson, FRCP Edin, FRCN, FAAN, Professor of Nursing Professor Keith Willison, PhD, Professor of Chemical Biology, Imperial, London Lord Moonie, MBChB, MRCPsych, MFCM, MSc, House of Lords, former parliamentary under-secretary of state 2001-2003, former consultant in Public Health Medicine Dr Najmiah K Ahmad, BM MRCA FCARCSI, Consultant Anaesthetist Dr Shiraz Akram, BDS, Dental surgeon Dr Victoria Anderson, MBChB, MRCGP, MRCPCH, DRCOG, General Practitioner Julie Annakin, RN, Immunisation Specialist Nurse Helen Auburn, Dip ION MBANT NTCC CNHC RNT, registered Nutritional Therapist Dr Ian Barros D’Sa, BM, MRCS, FRCR, PGCMEd, Consultant Radiologist Dr David Bell, MBBS, PhD, FRCP(UK) Dr Michael D Bell, MBChB, MRCGP, retired General Practitioner Dr Mark A Bell, MBChB, MRCP(UK), FRCEM, Consultant in Emergency Medicine, UK Dr Alan Black, MBBS, MSc, DipPharmMed, Retired Pharmaceutical Physician Dr Gillian Breese, BSc, MB ChB, DFFP, DTM&H, General Practitioner Dr Emma Brierly, MBBS, MRCGP, General Practitioner Mr John Bunni, MBChB (Hons), DipLapSurg, FRCS, Consultant Colorectal and General Surgeon Dr Elizabeth Burton, MB ChB, Retired General Practitioner Dr David Cartland, MBChB, BMedSci, General practitioner Dr Peter Chan, BM, MRCS, MRCGP, NLP, General Practitioner, Functional Medicine Practitioner Dr Marco Chiesa, MD, FRCPsych, Consultant Psychiatrist, Visiting Professor Michael Cockayne MSc, PG Dip, SCPHNOH, BA, RN Occupational Health Practitioner Mr Ian F Comaish, MA, BM BCh, FRCOphth, FRANZCO, Consultant ophthalmologist James Cook, NHS Registered Nurse, Bachelor of Nursing (Hons), Master of Public Health (MPH) Dr Clare Craig, BM BCh FRCPath Dr David Critchley, BSc, PhD, 32 years in pharmaceutical R&D as a clinical research scientist Dr Jayne LM Donegan, MBBS, DRCOG, DCH, DFFP, MRCGP, Homeopathic Practitioner Dr Jonathan Eastwood, BSc, MBChB, MRCGP, General Practitioner Dr Jonathan Engler, MBChB, LlB (hons), DipPharmMed Dr Elizabeth Evans, MA(Cantab), MBBS, DRCOG, Retired Doctor, Director UKMFA Dr Chris Exley, PhD FRSB, retired professor in Bioinorganic Chemistry Dr John Flack, BPharm, PhD. Retired Director of Safety Evaluation at Beecham Pharmaceuticals 1980-1989 and Senior Vice-president for Drug Discovery 1990-92 SmithKline Beecham Sophie Gidet, RM, Midwife Dr Ali Haggett, Mental health community work, 3rd sector, former lecturer in the history of medicine Mr David Halpin, MBBS, FRCS, Orthopaedic and trauma surgeon, retired Mr Anthony Hinton, MBChB, FRCS, Consultant ENT surgeon, London Dr Renee Hoenderkamp, General Practitioner Dr Andrew Isaac, MB BCh, Physician, retired Dr Keith Johnson, BA, D.Phil (Oxon), IP Consultant for Diagnostic Testing Dr Pauline Jones MB BS retired general practitioner Ancha Bala Joof, MBChB, MRCGP, General Practitioner Dr Timothy Kelly, MB BCh BSc, NHS doctor Dr Gemma Kemp, MBBS FRCPath, Consultant Forensic Pathologist Dr Tanya Klymenko, PhD, FHEA, FIBMS, Senior Lecturer in Biomedical Sciences Dr Sheena Fraser, MBChB, MRCGP (2003), Dip BSLM, General Practitioner Dr Caroline Lapworth, MB ChB, General Practitioner Dr Branko Latinkic, BSc, PhD, Molecular Biologist Dr Theresa Lawrie, MBBCh, PhD, Director, Evidence-Based Medicine Consultancy Ltd, Bath Dr Felicity Lillingstone, IMD DHS PhD ANP, Doctor, Urgent Care, Research Fellow Katherine MacGilchrist, BSc (Hons) Pharmacology, MSc Epidemiology, CEO, Systematic Review Director, Epidemica Ltd Dr C Geoffrey Maidment, MD, FRCP, retired consultant physician Mr Ahmad K Malik, FRCS (Tr & Orth), Dip Med Sport, Consultant Trauma & Orthopaedic Surgeon Dr Ayiesha Malik, MBChB, General Practitioner Dr Imran Malik, MBBS, MRCP, MRCGP, General Practitioner Dr Kulvinder S. Manik MBChB, MRCGP, MA(Cantab), LLM, Gray’s Inn Dr Fiona Martindale, MBChB, MRCGP, General Practitioner Mr Ian McDermott, MBBS, MS, FRCS(Tr&Orth), FFSEM(UK), Consultant Orthopaedic Surgeon Dr Graham Milne, MBChB, MRCGP, DRCOG, General Practitioner Dr Scott Mitchell, MBChB, MRCS, Associate Specialist, Emergency Medicine Dr Alan Mordue, MBChB, FFPH (ret). Retired Consultant in Public Health Medicine & Epidemiology Margaret Moss, MA(Cantab), CBiol, MRSB, Director, The Nutrition and Allergy Clinic, Cheshire Dr Claire Mottram, BSc Hons, MBChB, Doctor in General Practice Dr Greta Mushet, retired Consultant Psychiatrist in Psychotherapy. MBChB, MRCPsych Dr Angela Musso, MD, MRCGP, DRCOG, FRACGP, MFPC, General Practitioner Dr Sarah Myhill, MBBS, Dip NM, Retired GP, Independent Naturopathic Physician Dr Rachel Nicholl, PhD, Medical researcher Dr Christina Peers, MBBS, DRCOG, DFSRH, FFSRH, Menopause Specialist Rev Dr William J U Philip MB ChB, MRCP, BD, Senior Minister The Tron Church, Glasgow, formerly physician specialising in cardiology Anna Phillips, RSCN, BSc Hons, Clinical Lead Trainer Clinical Systems (Paediatric Intensive Care) Dr Angharad Powell, MBChB, BSc (hons), DFRSH, DCP (Ireland), DRCOG, DipOccMed, MRCGP, General Practitioner Dr Gerry Quinn, PhD, Microbiologist Jessica Righart, MSc, MIBMS, Senior Biomedical Scientist Mr Angus Robertson, BSc, MBChB, FRCSEd (Tr & Orth), Consultant Orthopaedic Surgeon Dr Susannah Robinson, MBBS, BSc, MRCP, MRCGP, General Practitioner Dr Jon Rogers, MB ChB (Bristol), Retired General Practitioner Mr James Royle, MBChB, FRCS, MMedEd, Colorectal Surgeon Dr Salmaan Saleem, MBBS, BMedSci, MRCGP, General Practitioner Dr Alia Sarwar, MBChB, General Practitioner Sorrel Scott, Grad Dip Phys, Specialist Physiotherapist in Neurology, 30 years in NHS Dr Rohaan Seth, Bsc (Hons), MBChB (Hons), MRCGP, Retired General Practitioner Dr Haleema Sheikh, MRCGP, General Practitioner Dr Magdalena Stasiak-Horkan MBBS, MRCGP (2017), DCH, General Practitioner Natalie Stephenson, BSc (Hons) Paediatric Audiologist Marco Tullio Suadoni, RN, BSc (Hons) Adult Nursing, MSc, Specialist Palliative Care Lead Dr Mashhood Syed, MBChB, DRCOG, MRCGP(2018), LFHom(Med) Dr Noel Thomas, MA, MBChB, DObsRCOG, DTM&H, MFHom, Retired Doctor Dr Stephen Ting, MBChB, MRCP, PhD, Consultant Physician Dr Livia Tossici-Bolt, PhD, NHS Clinical Scientist Dr Fodhla Treacy, MBBS, MRCGP, General Practitioner Dr Helen Westwood, MBChB (Hons), MRCGP, DCH, DRCOG, General Practitioner Dr Carmen Wheatley, DPhil, Orthomolecular Oncology Mr Lasantha Wijesinghe, FRCS, Consultant vascular surgeon Dr Ruth Wilde, MBBCh, MRCEM, AFMCP, Integrative & Functional Medicine Doctor Dr Lucie Wilk, MD, MRCP, Rheumatologist Dr Julia Wilkens, FRCOG, MD, Consultant in Obstetrics & Gynaecology Dr Ruqia Zafar, MBChB, MRCGP, General Practitioner
How to Contact Your Elected Officials Learn how to contact your federal, state, and local elected leaders. Federal Elected Officials Contact President Joe Biden online, or call the White House switchboard at 202-456-1414 or the comments line at 202-456-1111 during business hours. Locate your U.S. senators' contact information. Find your U.S. representative's website and contact information. State Elected Officials Get in touch with your state governor. Find the names and current activities of your state legislators. Local Elected Officials Locate your mayor by name, city, or population size. Find your county executive (the head of the executive branch of government in your county) by map search or your ZIP Code. The county executive may be an elected or an appointed position. Get contact information for your city, county, and town officials.
Deaths per 100,000 person years? WTH stat is that supposed to represent? People are mesmerized by charts, like TA folks, without understanding fundamentals. What is "per 100,000 person years"? Oh wait, I know, the scientists and analysts came up with that stat line because they grew up watching the movie Tron from 1982.
IDK exactly. It's an official stat, though, used by govs. I think it normalizes death to age at time of death so that age is not a confounder in the stats, because age is otherwise a -UUUGE confounder. EDIT: It appears to be number of people X observation time. ie, 2 persons observed for 6 months is 1 person-year.